Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $53 |
| Triangulated Fair Value | $41 |
| 12-mo Scenario PWEV | $56 |
| Implied Return | -21% |
| Forward P/E | 6.6x |
| Market Cap | $17B |
| 52-Week Range | $40 – $83 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Spike — Supply Dislocation' (8% weight) — targets $127, +142% vs spot. It needs Gross Margin to surprise to the upside.
The dashboard below is the whole argument on one page: spot ($53) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Petrochem Overcapacity / Demand Peak' (24%) — targets $15, -72% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
Gross Margin explains 51% of Monte Carlo outcome variance — the single variable that decides which side is right.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.56 vs analyst floor -0.01 → delta +0.57 (n=29 mgmt / 10 Q&A; 83th pctile across the S&P book, z +1.1).
Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.56 | -0.01 | +0.57 |
| 2025Q4 | +0.31 | +0.14 | +0.17 |
| 2025Q3 | +0.52 | +0.00 | +0.52 |
| 2025Q2 | +0.44 | +0.15 | +0.29 |
News (last 365d, 680 articles): avg ticker sentiment -0.08 (bullish 7% / bearish 33%)
Scenario Analysis
The tree runs from a structural 'Structural — Petrochem Overcapacity / Demand Peak' downside ($15) to a 'Spike — Supply Dislocation' bull case ($127); the probability-weighted blend (PWEV $56) is +5% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Petrochem Overcapacity / Demand Peak | 24% | $15 | -72% |
| Downturn — Trough Margins | 18% | $31 | -40% |
| Base — Mid-Cycle Spreads | 32% | $58 | +10% |
| Upcycle — Tight Spreads | 18% | $98 | +87% |
| Spike — Supply Dislocation | 8% | $127 | +142% |
| Probability-Weighted (PWEV) | — | $56 | +5% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Petrochem Overcapacity / Demand Peak (24%, $15). Structural impairment — capacity glut / demand peak: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 14.57; probability: 0.24.
- Downturn — Trough Margins (18%, $31). Cyclical downturn — petrochemical spreads (ethylene/PE/PP) + feedstock + global demand weakens for 1–2 years before normalising. Drivers — implied_target: 31.48; probability: 0.18.
- Base — Mid-Cycle Spreads (32%, $58). Mid-cycle — normalised petrochemical spreads (ethylene/PE/PP) + feedstock + global demand; disciplined capital allocation; steady returns. Drivers — implied_target: 57.7; probability: 0.32.
- Upcycle — Tight Spreads (18%, $98). Upside — supply dislocation / tight spreads lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 98.37; probability: 0.18.
- Spike — Supply Dislocation (8%, $127). Upside tail — sustained tight conditions or a structural re-rate on supply dislocation / tight spreads. Drivers — implied_target: 127.22; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $50 | -5% |
| Peer P/E re-rate | multiple | $180 | +243% |
| Peer EV/Revenue re-rate | multiple | $257 | +389% |
| Scenario PWEV | multiple | $56 | +5% |
| DCF (5-year + terminal) | cash flow + terminal × | $28 | -47% |
| Triangulated (weighted) | — | $41 | -21% |
peer P/E re-rate excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $50 + scenario PWEV $56, ≈ spot); the weighted blend $41 (-21%) sits below it because the cash-flow DCF ($28) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $50 and 48% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (51% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 9.5%, 6x terminal FCF multiple → $28. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 22.755000000000003x) implies $180. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is wide (genuine disagreement — low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Commodity Chemicals / Petrochemicals | $29.7B | 100% | 2% | 11% | 7x | 7% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | petrochemical spreads (ethylene/PE/PP) + feedstock + global demand |
| net_debt_or_cash_b | -11.61 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.07 |
| div_yield | 0.0855 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | capacity glut / demand peak |
| upside | supply dislocation / tight spreads |
Industry Context — Materials — Commodity
This name sits in the Materials — Commodity as a commodity_chem. petrochemical spreads (ethylene/PE/PP) + feedstock + global demand Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: DOW (commodity_chem) · LYB (commodity_chem) · ALB (lithium) · CF (fertilizer) · MOS (fertilizer)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Commodity Glut — Oversupply / Demand Reset | 42% | 42% | |
| Mid-Cycle — Normalised Prices | 32% | 32% | |
| Tight Market — Upcycle / Spike | 26% | 26% |
On the cluster's key downside — Commodity Glut — Oversupply / Demand Reset () — this name implies 42% vs the cluster house view of 42% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The commodity cycle is the shared macro driver. Driver — commodity-chemical / nutrient / lithium price cycle + feedstock costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $30B | $3B | $2B | $2B | $3B | $2B |
| FY+2 | $31B | $3B | $2B | $2B | $3B | $2B |
| FY+3 | $31B | $4B | $2B | $2B | $3B | $2B |
| FY+4 | $31B | $4B | $2B | $2B | $3B | $2B |
| FY+5 | $32B | $4B | $2B | $2B | $3B | $2B |
| Terminal | — | — | — | — | $3B × 6x | $10B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 7% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 9.5% · Σ PV(FCF) $10B + PV(terminal) $10B = EV $21B; + net cash → equity $9B ÷ diluted shares 0.32B = $28/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $74/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 3% vs WACC 10% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| SHW | 4.061x | 28.82x | 5% | 14% |
| ECL | 5.34x | 33.56x | 5% | 17% |
| PPG | 2.071x | 15.46x | 5% | 14% |
| IFF | 2.321x | 16.69x | 5% | 10% |
| Median | 3.191x | 22.755000000000003x | — | — |
Peer-median fwd P/E → $180; EV/Rev → $257.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $28 | 47% | $13 |
| Scenario PWEV | $56 | 33% | $19 |
| Monte Carlo median | $50 | 20% | $10 |
| Triangulated | — | 100% | $41 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC ＼ Term× | 4.2x | 5.1x | 6.0x | 6.9x | 7.8x |
|---|---|---|---|---|---|
| 8% | $22 | $27 | $32 | $38 | $43 |
| 8% | $20 | $25 | $30 | $35 | $40 |
| 10% | $18 | $23 | $28 | $32 | $37 |
| 10% | $16 | $21 | $25 | $30 | $35 |
| 12% | $14 | $19 | $23 | $28 | $32 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ ＼ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $8 | $15 | $23 | $31 | $38 |
| -1.5pp | $9 | $17 | $25 | $33 | $42 |
| +0.0pp | $10 | $19 | $28 | $36 | $45 |
| +1.5pp | $12 | $21 | $30 | $39 | $48 |
| +3.0pp | $13 | $23 | $33 | $42 | $52 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $10 | $45 | $34 |
| Terminal × ±15% | $23 | $32 | $10 |
| Revenue CAGR ±3pp | $23 | $33 | $10 |
| WACC ±1pp | $25 | $30 | $5 |
| FCF conversion ±10% | $28 | $28 | $0 |
Company lever — SoP/share vs Commodity Chemicals / Petrochemicals multiple (AI re-rating) (base 7x)
| Multiple | 4.9x | 6.0x | 7.0x | 8.0x | 9.1x |
|---|---|---|---|---|---|
| SoP/share | $415 | $516 | $608 | $700 | $801 |
Load-Bearing Assumptions
DCF: WACC 10%, terminal multiple 6×, FY+5 revenue $32B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
A miss on Gross Margin drops the case toward the structural target $15.
Fact / Inference / Speculation
- FACT: Spot $53; 52-week range $40–$83; engine rating HOLD; base-case target $56 (+5%).
- INFERENCE: Triangulated FV $41 (-21%). Gross Margin explains 51% of Monte Carlo outcome variance — the single variable that decides which side is right.
- SPECULATION: At current prices the embedded bet is that Gross Margin surprises to the upside — Gross Margin carries 51% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $58 (+10% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin (51% of variance) — a fundamental call. SBC runs —M TTM (disclosed in the appendix).